Differential protein expression in heart in UT-B null mice with cardiac conduction defects

Proteomics

Volumn 9, Issue 3, 2009, Pages 504-511

  Yu, Hao ^a   Meng, Yan ^a   Wang, Li Shun ^b   Jin, Xian ^b   Gao, Li Fang ^a   Zhou, Lei ^a   Ji, Kun ^a   Li, Yang ^a   Zhao, Li Juan ^a   Chen, Guo Qiang ^b   Zhao, Xue Jian ^a,d   Yang, Baoxue ^c  

^a JILIN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^d NONE   (China)

Author keywords

Cardiac conduction block; Differential protein expression; Urea transporter; UT B

Indexed keywords

ATRIAL NATRIURETIC FACTOR; MEMBRANE PROTEIN; PROTEIN UT B; TROPONIN T; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; HEART MUSCLE CONDUCTION DISTURBANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOTTING, WESTERN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HEART CONDUCTION SYSTEM; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, KNOCKOUT; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TROPONIN T;

MUS; MUS MUSCULUS;

EID: 60549102309     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200701079     Document Type: Article

References (37)

1. Gollob, M. H., Green, M. S., Tang, A. S., Gollob, T. et al., Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. New Engl. J. Med. 2001, 344, 1823-1831.
2. Gollob, M. H., Seger, J. J., Gollob, T. N., Tapscott, T. et al., Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy. Circulation 2001, 104, 3030-3033.
3. Saudubray, J. M., Martin, D., de Lonlay, P., Touati, G. et al., Recognition and management of fatty acid oxidation defects: a series of 107 patients. J. Inherit. Metab. Dis. 1999, 22, 488-502.
4. Ou, Y., Strege, P., Miller, S. M., Makielski, J. et al., Syntrophin gamma 2 regulates SCN5A gating by a PDZ domain-mediated interaction. J. Biol. Chem. 2003, 278, 1915-1923.
5. Smits, J. P., Koopmann, T. T., Wilders, R., Veldkamp, M. W. et al., A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families. J. Mol. Cell. Cardiol. 2005, 38, 969-981.
6. Tawil, R., Ptacek, L. J., Pavlakis, S. G., DeVivo, D. C. et al., Andersen's syndrome: Potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features. Ann. Neurol. 1994, 35, 326-330.
7. Lahat, H., Pras, E., Olender, T., Avidan, N. et al., A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am. J. Hum. Genet. 2001, 69, 1378-1384.
8. Thomas, S. A., Schuessler, R. B., Berul, C. I., Beardslee, M. A. et al., Disparate effects of deficient expression of connexin43 on atrial and ventricular conduction: Evidence for chamber- specific molecular determinants of conduction. Circulation 1998, 97, 686-691.
9. Liu, M. R., Pan, K. F., Li, Z. F., Wang, Y. et al., Rapid screening mitochondrial DNA mutation by using denaturing high-performance liquid chromatography. World J. Gastroenterol. 2002, 8, 426-430.
10. Timmer, R. T., Klein, J. D., Bagnasco, S. M., Doran, J. J. et al., Localization of the urea transporter UT-B protein in human and rat erythrocytes and tissues. Am. J. Phys. 2001, 281, C1318-C1325.
11. Yang, B., Bankir, L., Urea and urine concentrating ability: New insights from studies in mice. Am. J. Physiol. Renal. Physiol. 2005, 288, F881-F896.
12. Lucien, N., Sidoux-Walter, F., Olives, B., Moulds, J. et al., Characterization of the gene encoding the human Kidd blood group/urea transporter protein. Evidence for splice site mutations in Jknull individuals. J. Biol. Chem. 1998, 273, 12973-12980.
13. Sands, J. M., Gargus, J. J., Frohlich, O., Gunn, R. B., Kokko, J. P., Urinary concentrating ability in patients with Jk(a-b-) blood type who lack carrier-mediated urea transport. J. Am. Soc. Nephrol. 1992, 2, 1689-1696.
14. Meng, Y., Zhou, X., Li, Y., Zhao, D. et al., A novel mutation at the JK locus causing Jk null phenotype in a Chinese family. Sci. China, C, Life Sci. 2005, 48, 636-640.
15. Yang, B., Verkman, A. S., Analysis of double knockout mice lacking aquaporin-1 and urea transporter UT-B. Evidence for UT-B-facilitated water transport in erythrocytes. J. Biol. Chem. 2002, 277, 36782-36786.
16. Bankir, L., Chen, K., Yang, B., Lack of UT-B in vasa recta and red blood cells prevents urea-induced improvement of urinary concentrating ability. Am. J. Physiol. 2004, 286, F144-F151.
17. Guo, L., Zhao, D., Song, Y., Meng, Y. et al., Reduced urea flux across the blood-testis barrier and early maturation in the male reproductive system in UT-B-null mice. Am. J. Physiol. 2007, 293, C305-C312.
18. Meng, Y., Zhang, X. X., Zhao, H., Guo, L. et al., The changes of ECG and action potential in mice lacking urea transporter. Sci. China 2007, 37, 447-451.
19. Rabilloud, T., Brodard, V., Peltre, G., Righetti, P. G., Ettori, C., Modified silver staining for immobilized pH gradients. Electrophoresis 1992, 13, 264-266.
20. Tu, L. C., Yan, X., Hood, L., Lin, B., Proteomics analysis of the interactome of N-myc downstream regulated gene 1 and its interactions with the androgen response program in prostate cancer cells. Mol. Cell. Proteomics 2007, 6, 575-588.
21. Nakajima, K., Hamanoue, M., Takemoto, N., Hattori, T. et al., Plasminogen binds specifically to alpha-enolase on rat neuronal plasma membrane. J. Neurochem. 1994, 63, 2048-2057.
22. Blair, E., Redwood, C., de Jesus Oliveira, M., Moolman-Smook, J. C. et al., Mutations of the light meromyosin domain of the beta-myosin heavy chain rod in hypertrophic cardiomyopathy. Cir. Res. 2002, 90, 263-269.
23. Newsholme, P., Keane, D., Welters, H. J., Morgan, N. G., Life and death decisions of the pancreatic beta-cell: The role of fatty acids. Clin. Sci. (Lond.) 2007, 112, 27-42.
24. Burt, H. M., Jackson, J. K., Dryden, P., Salari, H., Crystal-induced protein tyrosine phosphorylation in neutrophils and the effect of a tyrosine kinase inhibitor on neutrophil responses. Mol. Pharm. 1993, 43, 30-36.
25. Das, S., Maitra, U., Functional significance and mechanism of eIF5-promoted GTP hydrolysis in eukaryotic translation initiation. Prog. Nucleic Acid Res. Mol. Biol. 2001, 70, 207-231.
26. Cho, Y., Somer, B. G., Amatya, A., Natriuretic peptides and their therapeutic potential. Heart Dis. 1999, 1, 305-328.
27. Dietz, J. R., Mechanisms of atrial natriuretic peptide secretion from the atrium. Cardiovasc. Res. 2005, 68, 8-17.
28. Woodard, G. E., Rosado, J. A., Brown, J., Expression and control of C-type natriuretic peptide in rat vascular smooth muscle cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 282, R156-R165.
29. Iyengar, S., Haas, G., Lamba, S., Orsinelli, D. A. et al., Effect of cardiac resynchronization therapy on myocardial gene expression in patients with nonischemic dilated cardiomyopathy. J. Card. Fail. 2007, 13, 304-311.
30. Luchner, A., Brockel, U., Muscholl, M., Hense, H. W. et al., Gender-specific differences of cardiac remodeling in subjects with left ventricular dysfunction: a population-based study. Cardiovasc. Res. 2002, 53, 720-727.
31. Morawietz, H., Szibor, M., Goettsch, W., Bartling, B. et al., Deloading of the left ventricle by ventricular assist device normalizes increased expression of endothelin ET(A) receptors but not endothelin-converting enzyme-1 in patients with end-stage heart failure. Circulation 2000, 102, III188- III193.
32. Gietzen, F. H., Leuner, C. J., Obergassel, L., Strunk-Mueller, C., Kuhn, H., Transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: feasibility, clinical benefit, and short term results in elderly patients. Heart 2004, 90, 638-644.
33. Rubattu, S. S. S., Valenti, V., Stanzione, R., Volpe, M., Natriuretic peptides: An update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases. Am. J. Hypertens. 2008, 21, 733-741.
34. Itoh, H., Nakao, K., Natriuretic peptide system. Nippon Rinsho 1997, 55, 1923-1936.
35. Gomes, A. V., Potter, J. D., Molecular and cellular aspects of troponin cardiomyopathies. Ann. N. Y. Acad. Sci. 2004, 1015, 214-224.
36. Gomes, A. V., Barnes, J. A., Harada, K., Potter, J. D., Role of troponin T in disease. Mol. Cell. Biochem. 2004, 263, 115-129.
37. Adamcova, M., Sterba, M., Simunek, T., Potacova, A. et al., Troponin as a marker of myocardiac damage in drug-induced cardiotoxicity. Exp. Opin. Drug Safety 2005, 4, 457-472.